GO
Loading...

Enter multiple symbols separated by commas

Merck & Co Inc

More

  • CHICAGO/ NEW YORK, May 22- As a virulent avian influenza outbreak continues to spread across the Midwestern United States, some egg-dependent companies are contemplating drastic steps- importing eggs from overseas or looking to egg alternatives. A spokeswoman for Archer Daniels Midland Co said that as egg supplies tighten and prices rise, the food processing...

  • May 22- EU Medicines Agency:. *EU Medicines Agency recommendations for May 2015. *Recommends approval of cholesterol drug Repatha from Amgen Inc.

  • CHICAGO and NEW YORK, May 22- As a virulent avian influenza outbreak continues to spread across the Midwestern United States, some egg-dependent companies are contemplating drastic steps: importing eggs from overseas or looking to egg alternatives. "Canada is short on eggs and has been buying heavily from the U.S. for the last several years," said Rick Brown, a...

  • Investors were waiting for news that could move share prices from many bigger companies including Bristol-Meyers Squibb Co, Amgen Inc and Celgene Corp. Hot topics at the American Society of Clinical Oncology conference in Chicago will include immuno oncology and CAR-T cell therapies. Shares in Juno Therapeutics Inc, Kite Pharma Inc, BlueBird Bio Inc and...

  • A hot biotech that may be the next Genentech Tuesday, 12 May 2015 | 7:00 AM ET
    Biotech

    This company has raised $1 billion to develop the Holy Grail in drugs: Have the body's own cells churn out proteins to fight disease.

  • Disruptor 50: No.1 Moderna Therapeutics Tuesday, 12 May 2015 | 7:00 AM ET
    Stéphane Bancel, president and founding CEO, Moderna Therapeutics

    A biotech company that helps the human body make the medicine it needs to cure a range of disease—from cancer to diabetes.

  • INTERVIEW-New-look GSK bets on consumer health spending Wednesday, 6 May 2015 | 7:19 AM ET

    LONDON, May 6- Consumers from New York to New Delhi are digging deeper in their pockets for over-the-counter remedies and health products, a trend GlaxoSmithKline is banking on to help shape the next chapter in its evolution. In the biggest shake-up in its 15- year history, GSK has just sold its cancer drugs to Novartis, while buying the Swiss group's vaccine...

  • Spending on this type of meds hit a new milestone Tuesday, 5 May 2015 | 12:01 AM ET
    Employees walk past a Merck sign in front of the company's building in Summit, New Jersey.

    That's up more than 10 percent from 2013 and up from $75 billion five years earlier, according to a new report.

  • Traders work on the floor of the New York Stock Exchange.

    U.S. stocks closed higher, following positive momentum from Europe, as investors looked to Fed speeches and data for signals on rate hike timing.

  • Top 5 stocks of the week and how to trade them Friday, 1 May 2015 | 2:21 PM ET
    Traders work on the floor of the New York Stock Exchange.

    CNBC Pro highlights the top performing stocks this week and analyzes whether the good times will continue.

  • DAX closes down 3%; Europe sells off as euro gains Wednesday, 29 Apr 2015 | 11:30 AM ET
    Federal Reserve building in Washington, D.C., U.S.

    European equities tumbled on Wednesday to close sharply lower as investors reacted to sharp gains in the euro against the dollar.

  • April 29- Pharmacy benefit manager Express Scripts Holding Co, which has aggressively negotiated lower costs of new hepatitis C drugs, on Wednesday said a new "focus area" will be subduing costs of a growing wave of pricey biotech cancer drugs. "This is going to be a much slower and much bigger effort over time than what you saw for hepatitis," Steve Miller, chief...

  • Investors on Fed statement, first-quarter GDP watch Wednesday, 29 Apr 2015 | 6:00 AM ET
    The Federal Reserve building in Washington.

    Investors will scrutinize US growth as the initial read on the first-quarter GDP comes ahead of a meeting statement from a 'data-dependent' Fed.

  • Asian equities retreat on lackluster earnings; Fed eyed Wednesday, 29 Apr 2015 | 3:30 AM ET

    Asian markets mostly fell on Wednesday as investors digested the raft of earnings due in the region and awaited the Federal Reserve's statement.

  • Investors on Fed watch as statement, GDP come out Tuesday, 28 Apr 2015 | 6:56 PM ET
    The Federal Reserve building in Washington.

    Investors will scrutinize US growth as the initial read on the first-quarter GDP comes ahead of a meeting statement from a 'data-dependent' Fed.

  • Traders work on the floor of the New York Stock Exchange.

    U.S.stocks closed mixed on Tuesday as investors eyed tech earnings and awaited the Federal Reserve's statement on Wednesday.

  • Dollar hits Pfizer; Merck 'blew away' estimates Tuesday, 28 Apr 2015 | 9:04 AM ET
    Tablets of Pfizer Inc.'s Lipitor and Merck & Co.'s Zocor.

    Pfizer reported a 4 percent drop in quarterly revenue, while Merck posted earnings that topped expectations.

  • Janet Yellen speaking on March 18, 2015.

    U.S. stock index futures indicated a flat open on Tuesday ahead of the two-day FOMC meeting, housing data and a busy day of earnings.

  • April 28- Merck& Co's shares jumped almost 5 percent after the U.S. drugmaker reported better-than-expected quarterly results and released favorable data late Monday about the safety of its Januvia diabetes drug. The second-largest U.S. drugmaker on Tuesday said it earned $953 million, or 33 cents per share, in the first quarter. That compared with $1.71...

  • Innovation driving big pharma: Pro   Tuesday, 28 Apr 2015 | 8:09 AM ET
    Innovation driving big pharma: Pro

    Seamus Fernandez, Leerink Partners, and Barbara Ryan, Clermont Partners, share their thoughts on what's driving big pharma profits.